Dashyant Dhanak Incyte Corp (INCY) insider trading activity

Dashyant Dhanak is EVP & Chief Scientific Officer of INCYTE CORP. Currently has a direct ownership of 58,968 shares of INCY, which is worth approximately $3.38 Million. The most recent transaction as insider was on Jul 14, 2023, when has been sold 8,056 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59K

0% 3M change

15.82% 12M change

Total Value Held $3.38 Million

Dashyant Dhanak Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 14 2023	BUY Grant, award, or other acquisition	-	8,056 Added 12.02%	58,968 Common Stock
Jul 03 2023	SELL Payment of exercise price or tax liability	$375,211 $62.08 p/Share	6,044 Reduced 10.61%	50,912 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	$241,596 $65.42 p/Share	3,693 Added 6.09%	56,956 Common Stock
Jan 26 2023	SELL Open market or private sale	$205,615 $85.0 p/Share	2,419 Reduced 4.34%	53,263 Common Stock
Jan 20 2023	BUY Grant, award, or other acquisition	-	4,980 Added 8.21%	55,682 Common Stock
Dec 12 2022	SELL Payment of exercise price or tax liability	$43,897 $82.36 p/Share	533 Reduced 1.04%	50,702 Common Stock
Jul 05 2022	SELL Payment of exercise price or tax liability	$172,844 $79.25 p/Share	2,181 Reduced 4.08%	51,235 Common Stock

Jul 02 2022	BUY Grant, award, or other acquisition	-	11,274 Added 17.43%	53,416 Common Stock
Jan 01 2022	BUY Grant, award, or other acquisition	-	8,678 Added 17.08%	42,142 Common Stock
Dec 10 2021	SELL Payment of exercise price or tax liability	$34,858 $65.4 p/Share	533 Reduced 1.57%	33,464 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	-	2,734 Added 7.44%	33,997 Common Stock
Oct 01 2021	SELL Open market or private sale	$26,713 $68.67 p/Share	389 Reduced 1.23%	31,263 Common Stock
Sep 01 2021	SELL Open market or private sale	$29,763 $76.71 p/Share	388 Reduced 1.21%	31,652 Common Stock
Aug 02 2021	SELL Open market or private sale	$30,144 $77.49 p/Share	389 Reduced 1.2%	32,040 Common Stock
Jul 02 2021	SELL Payment of exercise price or tax liability	$131,471 $83.58 p/Share	1,573 Reduced 4.63%	32,429 Common Stock
Jul 02 2021	BUY Grant, award, or other acquisition	-	7,853 Added 18.76%	34,002 Common Stock
Jul 01 2021	SELL Open market or private sale	$33,300 $84.09 p/Share	396 Reduced 1.49%	26,149 Common Stock
Jun 10 2021	SELL Open market or private sale	$334,515 $87.0 p/Share	3,845 Reduced 12.65%	26,545 Common Stock
Jun 10 2021	BUY Exercise of conversion of derivative security	$251,540 $65.42 p/Share	3,845 Added 11.23%	30,390 Common Stock
Jun 01 2021	SELL Open market or private sale	$33,231 $84.13 p/Share	395 Reduced 1.47%	26,545 Common Stock
May 03 2021	SELL Open market or private sale	$33,818 $85.4 p/Share	396 Reduced 1.45%	26,940 Common Stock
Apr 01 2021	SELL Open market or private sale	$32,302 $81.57 p/Share	396 Reduced 1.43%	27,336 Common Stock
Mar 01 2021	SELL Open market or private sale	$31,493 $79.73 p/Share	395 Reduced 1.4%	27,732 Common Stock
Feb 01 2021	SELL Open market or private sale	$122,040 $90.0 p/Share	1,356 Reduced 4.6%	28,127 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$62,869 $65.42 p/Share	961 Added 3.16%	29,483 Common Stock

Also insider at

DCPH

Deciphera Pharmaceuticals, Inc. Healthcare

EVP & Chief Scientific Officer

Dashyant Dhanak

EVP & Chief Scientific Officer

Wilmington, DE

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INCY shares.

Notify only if

Value

Insider Trading

Get notified when an Incyte Corp insider buys or sells INCY shares.

Notify only if

Operation

Value

Type

News

Receive news related to INCYTE CORP

Track Activities on INCY

Account